Correlation Between Morgan Stanley and Taigen Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Taigen Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Taigen Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Taigen Biopharmaceuticals Holdings, you can compare the effects of market volatilities on Morgan Stanley and Taigen Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Taigen Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Taigen Biopharmaceutica.

Diversification Opportunities for Morgan Stanley and Taigen Biopharmaceutica

-0.2

Correlation Coefficient

Morgan Stanley  Taigen Biopharmaceutica

Good diversification

The 3 months correlation between Morgan and Taigen is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Taigen Biopharmaceuticals Hold in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taigen Biopharmaceutica and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Taigen Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taigen Biopharmaceutica has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Taigen Biopharmaceutica go up and down completely randomly.

Pair Corralation between Morgan Stanley and Taigen Biopharmaceutica

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.42 times more return on investment than Taigen Biopharmaceutica. However, Morgan Stanley Direct is 2.37 times less risky than Taigen Biopharmaceutica. It trades about 0.0 of its potential returns per unit of risk. Taigen Biopharmaceuticals Holdings is currently generating about -0.04 per unit of risk. If you would invest  2,052  in Morgan Stanley Direct on December 5, 2024 and sell it today you would lose (11.00) from holding Morgan Stanley Direct or give up 0.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	93.22%
Values	Daily Returns

Morgan Stanley Direct  vs.  Taigen Biopharmaceuticals Hold

Morgan Stanley Direct

Risk-Adjusted Performance

Very Weak

Over the last 90 days Morgan Stanley Direct has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Taigen Biopharmaceutica

Risk-Adjusted Performance

Very Weak

Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Taigen Biopharmaceutica is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Morgan Stanley and Taigen Biopharmaceutica

The main advantage of trading using opposite Morgan Stanley and Taigen Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Taigen Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taigen Biopharmaceutica will offset losses from the drop in Taigen Biopharmaceutica's long position.

The idea behind Morgan Stanley Direct and Taigen Biopharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.